Anatomy News and Research RSS Feed - Anatomy News and Research

Groundbreaking molecular imaging agent developed to trace advanced prostate cancer

Groundbreaking molecular imaging agent developed to trace advanced prostate cancer

Anti-androgen hormonal therapy, also called chemical castration, can be an important defense against further disease progression for patients with prostate cancer that has traveled and grown in other areas, or metastasized-but some cases simply do not respond to this treatment. [More]
Complete analysis of small bone and joint orthopedic devices in the U.S. market

Complete analysis of small bone and joint orthopedic devices in the U.S. market

Reportbuyer.com has added a new market research report: U.S. Market for Small Bone & Joint Orthopedic Devices [More]
Lombard Medical showcases Aorfix Endovascular Stent Graft at SVS Annual Meeting

Lombard Medical showcases Aorfix Endovascular Stent Graft at SVS Annual Meeting

Lombard Medical, Inc., a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAA), showcased its Aorfix Endovascular Stent Graft at the 2014 Society for Vascular Surgery Annual Meeting in Boston, June 5-7. [More]
GW SMHS establishes new graduate certificate in anatomical and translational sciences

GW SMHS establishes new graduate certificate in anatomical and translational sciences

The George Washington University School of Medicine and Health Sciences is pleased to announce the establishment of a new graduate certificate in anatomical and translational sciences (GCATS). The first semester of the GCATS program will begin Aug. 25. [More]
Discovery may lead to relief for victims of range of neurological disorders

Discovery may lead to relief for victims of range of neurological disorders

University of Toronto biologists leading an investigation into the cells that regulate proper brain function, have identified and located the key players whose actions contribute to afflictions such as epilepsy and schizophrenia. [More]
Olympus' ENDOEYE FLEX 3D articulating videoscope earns top honors at ATA Showcase

Olympus' ENDOEYE FLEX 3D articulating videoscope earns top honors at ATA Showcase

Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions for medical and surgical procedures, among other core businesses, announced today that its ENDOEYE FLEX 3D articulating videoscope received top honors as the Breakthrough Technology of the Year. [More]
Gamma and neutron imaging safe and effective in simulations

Gamma and neutron imaging safe and effective in simulations

Gamma and neutron imaging offer possible improvements over existing techniques such as X-ray or CT, but their safety is not yet fully understood. [More]
STENTYS signs agreement to acquire assets of Cappella Peel Away

STENTYS signs agreement to acquire assets of Cappella Peel Away

STENTYS, a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), today announced the signing of the acquisition agreement of Cappella Peel Away Inc. (Delaware, USA) and its assets relating to a novel stent delivery system. The acquisition is subject to closing conditions. [More]
Researchers investigate correlation between lower back pain and genes

Researchers investigate correlation between lower back pain and genes

Lower back pain is a broad yet subtle subject. It has widely been associated with early degeneration of the discs of the human spine. [More]
FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

Trimel Pharmaceuticals Corporation announced today that the United States Food and Drug Administration (FDA) has approved Natesto (testosterone), formerly CompleoTRT, the first and only testosterone nasal gel for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. [More]
Researchers discover signaling pathway in cancer cells that invades nearby tissues

Researchers discover signaling pathway in cancer cells that invades nearby tissues

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a signaling pathway in cancer cells that controls their ability to invade nearby tissues in a finely orchestrated manner. [More]
Obama, under increasing pressure on VA, promises accountability after internal review

Obama, under increasing pressure on VA, promises accountability after internal review

As outrage grows about allegations of wrongdoing at VA facilities around the country, the president sticks by VA Secretary Eric Shinseki, at least for now. [More]
First Edition: May 22, 2014

First Edition: May 22, 2014

Today's headlines include coverage of the Senate Finance Committee vote to recommend Sylvia Mathews Burwell to head the Department of Health and Human Services. [More]
OSU's scientist leverages OSC systems to study 3-D model of ant anatomy

OSU's scientist leverages OSC systems to study 3-D model of ant anatomy

A recent study into the biomechanics of the necks of ants - a common insect that can amazingly lift objects many times heavier than its own body - might unlock one of nature's little mysteries and, quite possibly, open the door to advancements in robotic engineering. [More]
CardiAQ performs first-in-human Trans-Apical TMVI procedure

CardiAQ performs first-in-human Trans-Apical TMVI procedure

CardiAQ Valve Technologies (CardiAQ), which performed the first ever Trans-Femoral, Transcatheter Mitral Valve Implantation procedure in June of 2012 with its self-conforming, self-anchoring implant technology, announced today that it has achieved another milestone in cardiovascular medicine by successfully implanting its Second Generation Transcatheter Mitral Valve in an 88-year-old female suffering from severe mitral regurgitation (MR 4+) using the company's newly added Trans-Apical Delivery System. [More]
Inspire Medical Systems completes $40 million Series E financing

Inspire Medical Systems completes $40 million Series E financing

Inspire Medical Systems, Inc. announced today that it has completed a Series E financing of $40 million. The financing round was strategically timed to coincide with the commercial launch of the Inspire Upper Airway Stimulation (UAS) therapy in the United States. [More]
Medrobotics announces closing of $26M Series E Preferred Stock financing

Medrobotics announces closing of $26M Series E Preferred Stock financing

Medrobotics Corp., a surgical products company with core competencies in medical robotics, announced today that it had closed its $26 Million Series E Preferred Stock financing. Existing Medrobotics shareholders and undisclosed new investors participated in the Series E raise. Proceeds will be used for regulatory preparations and submissions and for anticipated commercial launches in Europe and the United States. [More]
Smart drugs have lasting side-effects on young people's brain

Smart drugs have lasting side-effects on young people's brain

Over a million American students misuse prescription drugs or take illegal stimulants to increase their attention span, memory, and capacity to stay awake. Such "smart drugs" become more and more popular due to peer pressure, stricter academic requirements, and the tight job market. But young people who misuse them risk long-term impairments to brain function, warn Kimberly Urban at the University of Delaware and Wen-Jun Gao at Drexel University College of Medicine, USA, in a NIH-funded review published in the open-access journal Frontiers in Systems Neuroscience. [More]
Preconditioning crush increases survival rate of motor neurons after spinal root avulsion

Preconditioning crush increases survival rate of motor neurons after spinal root avulsion

A previous study showed that, 1 week after avulsion of the spinal nerve root, small motor neurons (< 500 μm2) negative for 27 kDa heat shock protein (HSP27) immunoreactivity died and only large (> 500 μm2) HSP27-positive motor neurons survived in the spinal cord ventral horn. [More]

Results from Sorin Group's study on Freedom Solo presented at AATS 2014

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, is proud to announce the results of its trial on the Freedom Solo for approval on the US market presented at the 94th Annual Meeting of American Association for Thoracic Surgery in Toronto, Canada. [More]